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The dramatic increase of life expectancy during the 20th 
century represents one of the greatest achievements of 
the human society, but also creates new challenges to 
the sustainability of current national health systems [1, 
2]. The incidence and prevalence of age-related 
diseases, including cardiovascular diseases (CVD), 
increase exponentially with advancing age, both 
clinically and sub-clinically, and have an important 
impact on morbidity and mortality,  imposing  an  extra- 
 
ordinary economic toll on individuals and public health 
budgets. Hence, it is urgent to introduce innovative 
approaches to extend and/or restore the period of 
youthful health of older people [3]. 
 
The rising life expectancy within the older population 
itself is increasing the number and proportion of very 
old people. The global number of centenarians is 
projected to increase 10-fold between 2010 and 2050. 
Long living individuals (LLIs), that are 90 years of age 
or older, represent a class of subjects that can provide 






















The  study of  the health  status  in  long‐living  individuals  (LLIs) may help  identifying health‐span and  life‐span
determinants.  BPI‐Fold‐Containing‐Family‐B‐Member‐4  (BPIFB4)  protein  is  higher  in  healthy  vs.  non‐healthy
(frail) LLIs  serum and  its  longevity‐associated variant  forced expression  improves cardiovascular outcomes  in










RNA  expression.  In  conclusion, BPIFB4  and CXCR4  expression  classify  LLIs  health  status  that  correlates with
maintained MNCs migration. 
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the scientific community with an invaluable information 
about key determinants of human life span. Moreover, 
some LLIs are healthy, e.g. they escape age-associated 
diseases, while others are non-healthy, presenting or 
having a history of typical age-associated diseases. 
Thus, while comparison of LLIs versus young controls 
identifies genes associated with global longevity, the 
comparison of healthy-LLIs versus non-healthy-LLIs 
may provide fundamental insights into the mechanistic 
classifiers of the human health-span, and not aging 
itself. Nevertheless, the potential of the latter approach 
has not been thoroughly investigated. 
 
We recently identified four missense mutations (that 
allow mutant recombinant proteins experiments) among 
the top findings (p<0.0001) of our recent genome-wide 
association study on LLIs and controls of Cilento-Italy, 
and replicated them in two independent populations 
from US and Germany. This investigation led to the 
identification of a significant enrichment in LLIs of 
homozygous genotypes of the minor allele of rs2070325 
polymorphism (Ile229Val in BPIFB4). Strong linkage 
disequilibrium in BPIFB4 locus generated two 
alternative  haplotypes (the WT Ile229/Asn281/Leu488/ 
Ile494 and the longevity-associated-variant-LAV 
al229/Thr281/Phe488/Thr494; identifier: P59827.2). 
The LAV-BPIFB4 is phenotypically characterized by 
the activation of the endothelial nitric oxide synthase  
(eNOS) signalling pathway, leading to improvements in 
endothelial function, vascular reactivity to hypertensive 
stimuli, and regenerative capacity following ischemic 
insults [4]. BPIFB4 is a secreted serum protein and is 
also contained in circulating mononuclear cells. Its 
abundance may represent a classifier of healthy aging. 
In fact, we showed that high serum BPIFB4 protein 
levels identify healthy LLIs, distinguishing them from 
those affected by typical geriatric diseases [5]. 
 
Another powerful approach to unraveling the secret of 
longevity employs model organisms. Groundbreaking 
studies in the Caenorhabditis elegans, one of the 
principal models used to study aging, have shown that 
the hypoxia-inducible factor 1 (HIF-1) plays pivotal 
roles in the modulation of the regulatory networks that 
link oxygen homeostasis and aging [6, 7]. Under 
ischemic conditions, tissues are starved of nutrients and 
exposed to low oxygen levels, which trigger the HIF-1 
transcription, thus enabling the activation of adaptive 
responses to stress. HIF-1 is a heterodimer consisting of 
one alpha unit (HIF-1α, HIF-2α or HIF-3α) and one beta 
subunit (HIF-1β) [8]. HIF-1 can activate the 
transcription of more than 200 genes, constituting a 
significant portion of the hypoxia-induced transcription. 
Of note, HIF-1 targets are not limited to protein coding 
transcripts, but can also regulate noncoding RNAs, 
including microRNAs (miRNAs) and long noncoding 
RNAs [9]. In particular, we and others identified miR-
210 as a master “hypoxamiR” modulating cell 
metabolism and survival as well as angiogenesis [10]. 
By targeting, both directly and indirectly, several 
components of the oxidative phosphorylation 
mitochondrial machinery, miR-210 expression impacts 
on metabolism, contributing to the switch towards 
glycolysis observed in hypoxia [11]. Moreover, miR-
210 expression in normoxic endothelial cells stimulates 
the formation of capillary-like structures, and VEGF-
driven cell migration, at least in part, by targeting 
ephrin-A3 (EFNA3) adhesion molecule [12]. 
Additionally, miR-210 expressing cells display 
increased angiogenic factor signaling [13-15]. 
According with a pro-angiogenic role of miR-210, 
tissue perfusion and capillary density in mouse ischemic 
hindlimbs are both increased by the injection of CD34+ 
umbilical cord blood cells expressing miR-210 [16] and 
miR-210 overexpression induces angiogenesis in the 
normal adult mouse brain [17]. 
 
Circulating mononuclear cells (MNCs) are involved in 
vascular repair and regeneration, which led to the 
proposal of assessing the MNC trascriptome and function 
for an improved classification of cardiovascular reactivity 
to injury [18-21]. Thus, we hypothesize that the 
assessment of gene transcripts in MNCs may inform on 
the organism potential to maintain the cardiovascular 
homeostasis during aging. In the attempt to find 
genes/miRNAs associated with either life-span or health-
span, we here conducted a gene expression analysis of 
BPIFB4 together with a set of RNAs under the control of 
HIF-1α in peripheral blood MNCs from healthy-, non-
healthy-LLIs and young controls. Results indicate that 
both BPIFB4 and a certain HIF-1α-associated genes are 




Components of the BPIFB4 and HIF-1α 
pathway classify healthy long-living individuals 
 
RNA expression levels of BPIFB4 and components of 
the ischemia-responding HIF-1α pathway (namely 
CXCR4, AK3, ALDO-C, ADM, VEGF-A, GLUT-1 and 
miR-210) were measured in peripheral blood circulating 
MNCs. Few HIF-1α targets were selected as an 
example of the multiple cell function controlled by this 
transcription factor, i.e. angiogenesis and survival 
(ADM, VEGF-A and miR-210), glucose metabolism 
(ALDO-C, GLUT-1), migration (CXCR4), and cellular 
homeostasis (AK3). 
 
Table 1 shows the characteristics of the 45 LLIs and 63 
controls analyzed in the differential expression 
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analyses. Mean age was 97.4 years for LLIs, 44.1 years 
in the control group. Gender distribution was similar in 
the two groups (p=0.8). Among the LLIs, 31 (68.9%) 
were frail. The diagnoses included 5 cases of diabetes 
(16.1%), 10 CVD (32.3%), 3 diabetes and CVD (9.7%), 
8 Alzheimer or dementia (25.8%), 1 Alzheimer and 
CVD (3.2%), 2 respiratory diseases (6.5%), 1 
rheumatoid arthritis (3.2%) and 1 rheumatoid arthritis 
and CVD (3.2%).  
 
In the comparison between the total LLI population and 
controls, we found a reduction of ADM (median 
(range): 0.46 (0.02-1.34) vs. 1.02 (0.23-10.18) 
p<0.0001), ALDO-C (median (range): 0.76 (0.12-2.21) 
vs. 0.90 (0.38-2.95) p=0.008), GLUT-1 (median (range): 
0.38 (0.01-1.56) vs. 1.01 (0.37-2.85) p<0.0001) and 
VEGF-A (median (range): 0.61 (0.02-1.95) vs. 0.86 
(0.23-5.89) p=0.003) whereas miR-210 was increased 
(median (range): 2.13 (0.02-98.64) vs. 1.16 (0.01-11.32) 
p=0.03) (all data are expressed as 2ddCt relative 
expression values). In contrast, BPIFB4, CXCR4 and 
AK3 mRNA levels did not differ between the two 


































When analyzing the LLIs cohort according to the health 
condition, healthy-LLIs showed significantly lower 
levels of VEGF-A (median (range): 0.30 (0.02-1.62) vs. 
0.72 (0.77-1.95) p=0.04) and GLUT-1 (median (range): 
0.31 (0.01-1.42) vs 0.41 (0.19-1.56) p=0.03) in line with 
their inverse correlation with life-span. Unique to the 
comparison of the two LLI sub-groups, BPIFB4 levels 
were higher in healthy- as compared to non-healthy 
LLIs (median (range): 1.70 (0.37-78.26) vs. 0.56 (0.13-
59.12) p=0.004) whereas CXCR4 expression was lower 
in healthy- as compared to non-healthy LLIs (median 
(range): 0.62 (0.07-4.94) vs. 1.38 (0.10-3.85) p=0.04) 
(Figure 2).  The expression of CXCR4 and BPIFB4 
mRNA levels were confirmed to be independently 
associated to the health status among LLIs in a 
multivariable logistic model. The odds ratio associated 
with a doubling expression levels was 0.62 for CXCR4 
(95% CI 0.38 to 0.99, p=0.049) and 1.56 (95% CI 1.07 
to 2.28, p=0.02) for BPIFB4. This means that health 
status among LLIs is positively associated with BPIFB4 
and negatively associated with CXCR4 (OR=2.51; 95% 
CI: 1.31-4.82, p=0.05 when BPIFB4 doubles and 





































n Age mean (SD)  Age range Gender (M/F) 
Controls 63 44.1 (15.5) 20-78 24/39 
LLIs 45 97.4 (3.4) 92-106 16/29 
Healthy-LLIs 14 99.1 (3.3) 93-106 1/13 
Non-Healthy-LLIs 31 96.6 (3.3) 92-105 15/16 





n Age mean (SD)  Age range Gender (M/F) 
Healthy-LLIs 7 93.0 (3.8) 90-101 1/6 
Non-Healthy-LLIs 5 92.4 (2.1) 90-95 3/2 
Healthy‐LLIs,  healthy‐aged  long‐living  individuals; Non‐Healthy‐LLIs,  frail  long‐living  individuals  affected 
with diabetes, cardiovascular disease, Alzheimer’s disease or dementia. 
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CXCR4 levels identify LLIs with functional MNCs  
 
CXCR4 expression characterizes a class of MNCs with 
regenerative ability that is recruited in the context of 



















































results of low CXCR4 levels association with health 
status was counterintuitive and led us to assess if MNCs 
from healthy-LLIs respond to CXCR4 ligand SDF-1α 























































Number  of  MNCs  migrated  in  the  lower  chamber  toward  vehicle  (migration  medium  containing  0.1%  serum  bovine  albumin,  BSA)  or
chemoattractant  SDF‐1α  (CXCL12)  is  shown.  (B)  Percentage  of  CXCR4  (SDF‐1α  receptor)‐positive MNCs was measured  by  flow  cytometry  in
migrated (MIG) and not migrated (NOT MIG) harvested from the upper and lower chamber of the migration system respectively. Results of the 12
donors are shown in the dot plot. (C) Representative flow cytometry plot showing CXCR4pos MNCs in migrated and not migrated fractions. Negative
control  (Neg CTRL)  indicates not stained MNCs.  (D‐F) Association analysis of SDF‐1α‐migrated MNCs and percentage of CXCR4pos cells  (P=0.04),
percentage of CXCR4pos cells and CXCR4 relative expression (P=0.04), and SDF‐1α‐migrated MNCs and CXCR4 relative expression (P=0.06).  
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In vitro migration assay toward SDF-1α was performed 
using MNCs isolated from a new group of 12 LLI 
donors (N=7 healthy and N=5 non-healthy) described in 
Table 2. Non-healthy donor MNCs were functionally 
impaired (Figure 3A). Flow cytometry (FACS) analyses 
of migrated and non-migrated cells evidenced that non-
healthy donors had a lower percentage of cells 
expressing membrane CXCR4 (Figure 3B-C). As 
expected, the number of SDF-1α-migrated cells was 
directly associated with the percentage of FACS 
CXCR4-positive MNCs (rho=0.6, p=0.04) pointing at 
the need of CXCR4 for migration (Figure 3D). 
Importantly, in the analysis of the association between 
CXCR4 RNA expression levels and CXCR4 positive 
migrated cells we found inverse correlation (rho=0.9, 
p=0.04) (Figure 3E). Similar inverse trend was observed 
in the correlation between CXCR4 RNA and number of 
migrated cells (rho=0.5, p=0.06) (Figure 3F). The 
CXCR4 protein abundance did not change in two LLI 





There is a remarkable paucity of data regarding 
classifiers of healthy longevity, which can help generate 
new hypotheses and strategies to implement wellbeing 
in the general population. This study investigates the 
association of two candidate pathways with extreme 
longevity and healthy longevity. One pathway was 
deducted from genome-wide association studies in 
humans and the other from data on the C. elegans 
lifespan model. Results indicate that the same set of 
genes in the studied pathways has a different value as a 
classifier of general or healthy longevity. 
 
We have recently focused our efforts on LLIs and 
young controls recruited in Cilento, a rural area of 
southern Italy (the Southern Italian Centenarian Study-
SICS) discovering the association of rs2070325 in 
BPIFB4 gene to LLI [4, 23]. This longevity-associated 
variant of the BPIFB4 gene exerts vascular protection 
via activation of the eNOS pathway and stimulates 
regeneration through recruitment of pro-angiogenic 
cells. BPIFB4 is expressed in the CD34+ sub-fraction of 
circulating MNCs, which is acknowledged to participate 
in vascular repair of ischemic tissues [4]. Interestingly, 
BPIFB4 was more abundantly expressed in CD34+ cells 
from LLIs as compared to young controls. Follow up 
study on serum of healthy-LLIs vs. frail-LLIs showed 
that protein levels correlate with extreme longevity and 
that the protein amount is able to discriminate between 
healthy- and non-healthy LLIs [5]. Here, we show that 
BPIFB4 mRNA levels are also elevated in the total 
MNC fraction from healthy LLIs as compared with non-
healthy LLIs, in line with previous findings obtained in 
serum. On the other hand, differently from results in 
serum, the comparison of BPIFB4 mRNA levels in 
MNCs of LLIs and young controls showed no 
difference between the two groups. Therefore, the 
assessment of BPIFB4 in MNCs may help achieve a 
more specific determination of the health status of LLIs 
rather than life-span. MNCs represent a heterogeneous 
population with multifunctional properties. Further 
studies are necessary to understand if BPIFB4 
expression levels in a particular cellular sub-fraction 
provide better indication on healthy lifespan.  
  
The use of C. elegans models unveiled a complex role 
for HIF-1 as a longevity regulator. Indeed, several 
studies identified the HIF-1-mediated hypoxic response 
as an important longevity-promoting pathway that is 
distinct from insulin-like signaling and dietary 
restriction [24]. Interestingly, life-extending effects of 
HIF-1 are caused, at least in part, by the interplay 
between neuronal and intestinal cells. Indeed, HIF-1 
activation in neurons increases serotonergic signaling, 
leading to higher levels of flavin-containing 
monooxygenase-2 in the intestine, which increased 
longevity [25]. However, other investigations also 
identified a longevity-limiting role for HIF-1 (i.e. 
deletion increases life span), highlighting the complex 
relationship between HIF and aging [24]. 
 
The present study provides a possible key of 
interpretation for the above discrepancies, as HIF-1 
targets behaved differently as classifiers, with GLUT-1, 
ALDO-C, and VEGF-A being lower and miR-210 
higher in the global population of LLIs. ALDO-C and 
miR-210 were similarly distributed between the healthy 
and non-healthy LLIs, making these factors promising 
candidates for life-span, but not for health-span 
determination. In contrast, VEGF-A and GLUT-1 were 
good classifiers of both life-span and health-span. 
Intriguingly, a decreased expression of CXCR4 showed 
a significant association with prolonged health-span and 
not with life-span, similarly to what observed with 
BPIFB4 mRNA levels. Thus, the two genes may 
provide a unique expressional signature of health 
conservation with aging independent of life-span.  
 
CXCR4 is a seven transmembrane, G-protein-coupled, 
alpha-chemokine receptor specific for SDF-1α. CXCR4 
gene down-regulation, as observed in healthy-LLIs, did 
not result in reduced migratory activity following 
chemokine stimulation since healthy-LLIs MNCs 
migrated efficiently while frail-LLIs cells were 
impaired. Moreover, the number of cells responsive to 
SDF-1α induced migration is proportional to the 
percentage of CXCR4 protein-positive cells, whereas 
CXCR4 RNA levels appeared to be inversely correlated 
with the percentage of membrane CXCR4-positive 
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MNCs. Therefore, high CXCR4 expression in the non-
healthy group may represent a futile rescue mechanism 
to restore the lack of membrane protein needed for 
migration. Interpretation of these results in chronic 
ischemic diseases may be even more complex when 
considering that a previous study from our group has 
shown that SDF-1-induced migration of 
CD45(dim)CD34+CXCR4+KDR+ MNCs was higher in 
patients with cardiovascular death, forecasting 
cardiovascular mortality independently of other 
validated predictors, such as age, diagnosed coronary 
artery disease, serum C-reactive protein, and estimated 
glomerular filtration rate [21]. It would be valuable to 
verify if silencing or enhancing BPIFB4 and CXCR4 
expression in MNCs from healthy- or non-healthy-LLIs 
alters different MNC functions. 
 
The observed discrepancy between different HIF targets 
was somewhat surprising. However, it could be due to 
different HIF isoforms acting on distinct targets in a cell 
specific manner [26]. Moreover, HIF-1 and HIF-2 
transcriptional activity largely depends on the chromatin 
context and on the concomitant action of other 
transcriptional factors and cofactors that can determine 
the activation (or the lack of) of individual promoters 
and enhancers [27, 28].  
 
Very interesting is also the association of increased 
miR-210 levels with LLI. One can speculate that this 
might be related to the cell migration stimulatory 
function of miR-210 [29] [12]. However, miR-210 
impact on mitochondrial metabolism and reactive 
oxygen species production might also be important [11]. 
In conclusion, we here confirm the role of BPIFB4 and 
provide novel evidence for CXCR4 being a classifier of 
healthy aging. Further investigations are granted to 
confirm the potential of HIF targets and miR-210 to 
discriminate between LLIs and controls and between 
healthy versus non-healthy LLIs. Finally, we show that 
the comparison of healthy versus non-healthy LLIs is a 
possible strategy for the identification of genes/proteins 




Patient recruitment and classification 
 
We enrolled, by home visiting, and collected 
anamnestic information from a group of LLIs 
(individuals older than 90 years of age) from 
community-dwelling people based in a rural area of 
southern Italy (Cilento) in the attempt to identify 
molecular classifiers of healthy aging [4, 23]. Controls 
were healthy donors recruited in the same geographic 
area of the LLIs, with an age range between 20 and 80 
years old. LLIs were sub-classified as frail or healthy by 
the presence of systemic diseases (which includes 
diabetes mellitus, cardiovascular diseases (CVDs), 
Alzheimer or dementia, respiratory diseases, 
rheumatoid arthritis). All the patients were recruited in 
the same period of time and the collected blood samples 
processed within 24h since the withdrawn.  
 
All subjects donated blood samples for DNA study and 
gave written informed consent to the study, which was 
approved by IRCCS MultiMedica Ethical Committee, 
CE/CE/42/2010/LDC, protocol N. “19 2010 
Cardiovascolare”. The study was conducted in 
accordance with the ethical principles that have their 




PB (15mL) was withdrawn through a forearm vein 
puncture and MNCs were separated on Histopaque-
1077 (Sigma-Aldrich) gradient at 1200xg. 
 
RNA extraction and TaqMan quantitative Real 
Time PCR analysis 
 
RNA was extracted from MNCs using miRNeasy kit 
(Qiagen) following the manufacturer’s instructions. The 
concentration of and integrity of RNA was determined 
using the Nanodrop ND1000 Spectrophotometer 
(Thermo Scientific). RNA reverse transcription to 
measure miR-210 was performed with the TaqMan miR 
reverse transcription kit following the manufacturer’s 
instructions (Applied Biosystems). miR expression was 
analyzed by QuantStudio™ 6 Flex Real-Time PCR 
System (Applied Biosystems) and normalized to the U6 
small nucleolar RNA (snRU6). For gene expression 
analyses, single-strand complementary DNA (cDNA) 
was synthesized from 1 μg of total RNA using TaqMan 
Reverse Transcription reagents (Applied Biosystems). 
Quantitative RT-PCR was performed with the 
QuantStudio™ 6 Flex Real-Time PCR System (Applied 
Biosystems) using the following primers: 18s rRNA 
(forward 5’-CGCAGCTAGGAATAATGGAATAGG-
3’; reverse 5’-CATGGCCTCAGTTCCGAAA-3’), AK3 
(forward: 5’-CGTTGGATTCACCCTCCTAGC-3’; re-
verse: 5’-GCTGGACTAACGGTTCACCA-3’), VEGF-A  
(forward 5’- CAACATCACCATGCAGATTATGC -3’; 
reverse 5’- TCGGCTTGTCACATTTTTCTTGT -3’), 
CXCR4 
(forward: 5’-CAGTGGCCGACCTCCTCTT-3’; rever-
se: 5’-GGACTGCCTTGCATAGGAAGTT-3’); ALDO-C  
(forward: 5’-GGCTGCCACTGAGGAGTTC-3’; rever-
se: 5’-CTGCTGCTCCACCATCTTCT-3’).3’), GLUT-1 
(forward: 5’-GATTGGCTCCTTCTCTGTGG-3’, 
reverse: 5’-TCAAAGGACTTGCCCAGTTT-3’), ADM 
(forward: 5’-GGAAGAGGGAACTGCGGATGT-3’, 
reverse: 5’-GGCATCCGGACTGCTGTCT-3’). Data 
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were normalized to 18S ribosomal RNA as an 
endogenous control. For both miR and gene expression, 
each PCR reaction was performed in triplicate and 




For MNC migration assay 3μm pore-size filter-
equipped transwell chambers (Corning) coated with 
fibronectin 2 μg/mL were used. Cells (5x106) were 
placed in the upper chamber and allowed to migrate 
toward stromal derived factor-1 alpha (SDF-
1α/CXCL12)(R&D) (100 ng/mL) or vehicle (control) at 
37°C. The assay was stopped after 18 hours and cells 
that migrated to the lower chamber and cells that not 





For extracellular CXCR4 analysis, MNCs (2x105 cells) 
migrated and not-migrated were palced in separated 
tubes and stained with 5 μL of CXCR4 (APC) antibody 
(BD Biosciences). After 15 min incubation at room 
temperature in the dark, cells were washed, resuspended 
in PBS and analyzed. For each test, percentage of 
positive cells was analyzed using a FACSCanto flow 





Categorical variables were compared using the chi-
squared test. The Wilcoxon rank-sum test was used to 
compare the genes and miR expression levels between 
LLIs and controls. Correlation between continuous 
variables was evaluated using the Spearman coefficient. 
Multivariable logistic regression models were fitted to 
evaluate the independent effect of mRNA expression 
levels that resulted significantly associated with life-
span and heath-span from the univariate analyses. 
Expression levels were log2-transformed prior to 
regression analysis since their distribution was 
positively skewed. 
 
All reported p-values are two-sided. A p-value <0.05 
was considered statistically significant. Statistical 
analyses were performed with STATA 12 software 
(StataCorp. 2011. Stata Statistical Software: Release 12. 
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